Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only. In a liposome drug product, the drug substance is contained in liposomes. Typically, water soluble drugs are contained in the aqueous compartment(s) and hydrophobic drugs are contained in the lipid layer(s) of the liposomes. Release of drugs from liposome formulations can be modified by the presence of polyethylene glycol and/or cholesterol or other potential additives in the liposome.
The global Liposome Drug Delivery market is projected to reach US$ 8760.1 million by 2030 from an estimated US$ 4252.6 million in 2024, at a CAGR of 12.8% during 2024 and 2030.
Global Liposome Drug Delivery key players include Gilead Sciences, Pacira, Sun Pharmaceutical, Johnson & Johnson, Luye Pharma, etc. Global top five manufacturers hold a share about 60%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both with a share about 30 percent. In terms of product, Liposomal Doxorubicin is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer & Tumor Therapy, followed by Fungal Infection Therapy, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liposome Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Liposome Drug Delivery.
The Liposome Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Vial) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liposome Drug Delivery market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liposome Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
Segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segment by Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Liposome Drug Delivery in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Liposome Drug Delivery manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposome Drug Delivery sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Liposome Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Liposome Drug Delivery Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposome Drug Delivery Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liposome Drug Delivery Market Size Estimates and Forecasts
2.1.1 Global Liposome Drug Delivery Revenue 2019-2030
2.1.2 Global Liposome Drug Delivery Sales 2019-2030
2.2 Liposome Drug Delivery Market Size by Region: 2023 Versus 2030
2.3 Liposome Drug Delivery Sales by Region (2019-2030)
2.3.1 Global Liposome Drug Delivery Sales by Region: 2019-2024
2.3.2 Global Liposome Drug Delivery Sales Forecast by Region (2025-2030)
2.3.3 Global Liposome Drug Delivery Sales Market Share by Region (2019-2030)
2.4 Liposome Drug Delivery Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Liposome Drug Delivery Revenue by Region: 2019-2024
2.4.2 Global Liposome Drug Delivery Revenue Forecast by Region (2025-2030)
2.4.3 Global Liposome Drug Delivery Revenue Market Share by Region (2019-2030)
3 Global Liposome Drug Delivery by Manufacturers
3.1 Global Top Liposome Drug Delivery Manufacturers by Sales
3.1.1 Global Liposome Drug Delivery Sales by Manufacturer (2019-2024)
3.1.2 Global Liposome Drug Delivery Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Liposome Drug Delivery Manufacturers by Revenue
3.2.1 Global Liposome Drug Delivery Revenue by Manufacturer (2019-2024)
3.2.2 Global Liposome Drug Delivery Revenue Share by Manufacturer (2019-2024)
3.3 Global Liposome Drug Delivery Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Liposome Drug Delivery Manufacturers Covered: Ranking by Revenue
3.4.2 Global Liposome Drug Delivery Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Liposome Drug Delivery Manufacturing Base Distribution, Product Type
3.5.1 Liposome Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Liposome Drug Delivery Product Type
3.5.3 Date of International Manufacturers Enter into Liposome Drug Delivery Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Gilead Sciences
4.1.1 Gilead Sciences Company Information
4.1.2 Gilead Sciences Description, Business Overview
4.1.3 Gilead Sciences Liposome Drug Delivery Products Offered
4.1.4 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Gilead Sciences Liposome Drug Delivery Sales by Product in 2023
4.1.6 Gilead Sciences Liposome Drug Delivery Sales by Application in 2023
4.1.7 Gilead Sciences Liposome Drug Delivery Sales by Geographic Area in 2023
4.1.8 Gilead Sciences Recent Developments
4.2 Pacira
4.2.1 Pacira Company Information
4.2.2 Pacira Description, Business Overview
4.2.3 Pacira Liposome Drug Delivery Products Offered
4.2.4 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.2.5 Pacira Liposome Drug Delivery Sales by Product in 2023
4.2.6 Pacira Liposome Drug Delivery Sales by Application in 2023
4.2.7 Pacira Liposome Drug Delivery Sales by Geographic Area in 2023
4.2.8 Pacira Recent Developments
4.3 Sun Pharmaceutical
4.3.1 Sun Pharmaceutical Company Information
4.3.2 Sun Pharmaceutical Description, Business Overview
4.3.3 Sun Pharmaceutical Liposome Drug Delivery Products Offered
4.3.4 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Sun Pharmaceutical Liposome Drug Delivery Sales by Product in 2023
4.3.6 Sun Pharmaceutical Liposome Drug Delivery Sales by Application in 2023
4.3.7 Sun Pharmaceutical Liposome Drug Delivery Sales by Geographic Area in 2023
4.3.8 Sun Pharmaceutical Recent Developments
4.4 Johnson & Johnson
4.4.1 Johnson & Johnson Company Information
4.4.2 Johnson & Johnson Description, Business Overview
4.4.3 Johnson & Johnson Liposome Drug Delivery Products Offered
4.4.4 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.4.5 Johnson & Johnson Liposome Drug Delivery Sales by Product in 2023
4.4.6 Johnson & Johnson Liposome Drug Delivery Sales by Application in 2023
4.4.7 Johnson & Johnson Liposome Drug Delivery Sales by Geographic Area in 2023
4.4.8 Johnson & Johnson Recent Developments
4.5 Luye Pharma
4.5.1 Luye Pharma Company Information
4.5.2 Luye Pharma Description, Business Overview
4.5.3 Luye Pharma Liposome Drug Delivery Products Offered
4.5.4 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Luye Pharma Liposome Drug Delivery Sales by Product in 2023
4.5.6 Luye Pharma Liposome Drug Delivery Sales by Application in 2023
4.5.7 Luye Pharma Liposome Drug Delivery Sales by Geographic Area in 2023
4.5.8 Luye Pharma Recent Developments
4.6 Sigma-Tau
4.6.1 Sigma-Tau Company Information
4.6.2 Sigma-Tau Description, Business Overview
4.6.3 Sigma-Tau Liposome Drug Delivery Products Offered
4.6.4 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Sigma-Tau Liposome Drug Delivery Sales by Product in 2023
4.6.6 Sigma-Tau Liposome Drug Delivery Sales by Application in 2023
4.6.7 Sigma-Tau Liposome Drug Delivery Sales by Geographic Area in 2023
4.6.8 Sigma-Tau Recent Development
4.7 Ipsen (Onivyde)
4.7.1 Ipsen (Onivyde) Company Information
4.7.2 Ipsen (Onivyde) Description, Business Overview
4.7.3 Ipsen (Onivyde) Liposome Drug Delivery Products Offered
4.7.4 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.7.5 Ipsen (Onivyde) Liposome Drug Delivery Sales by Product in 2023
4.7.6 Ipsen (Onivyde) Liposome Drug Delivery Sales by Application in 2023
4.7.7 Ipsen (Onivyde) Liposome Drug Delivery Sales by Geographic Area in 2023
4.7.8 Ipsen (Onivyde) Recent Development
4.8 CSPC
4.8.1 CSPC Company Information
4.8.2 CSPC Description, Business Overview
4.8.3 CSPC Liposome Drug Delivery Products Offered
4.8.4 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.8.5 CSPC Liposome Drug Delivery Sales by Product in 2023
4.8.6 CSPC Liposome Drug Delivery Sales by Application in 2023
4.8.7 CSPC Liposome Drug Delivery Sales by Geographic Area in 2023
4.8.8 CSPC Recent Development
4.9 Teva Pharmaceutical
4.9.1 Teva Pharmaceutical Company Information
4.9.2 Teva Pharmaceutical Description, Business Overview
4.9.3 Teva Pharmaceutical Liposome Drug Delivery Products Offered
4.9.4 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.9.5 Teva Pharmaceutical Liposome Drug Delivery Sales by Product in 2023
4.9.6 Teva Pharmaceutical Liposome Drug Delivery Sales by Application in 2023
4.9.7 Teva Pharmaceutical Liposome Drug Delivery Sales by Geographic Area in 2023
4.9.8 Teva Pharmaceutical Recent Development
4.10 Novartis
4.10.1 Novartis Company Information
4.10.2 Novartis Description, Business Overview
4.10.3 Novartis Liposome Drug Delivery Products Offered
4.10.4 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.10.5 Novartis Liposome Drug Delivery Sales by Product in 2023
4.10.6 Novartis Liposome Drug Delivery Sales by Application in 2023
4.10.7 Novartis Liposome Drug Delivery Sales by Geographic Area in 2023
4.10.8 Novartis Recent Development
4.11 Fudan-Zhangjiang
4.11.1 Fudan-Zhangjiang Company Information
4.11.2 Fudan-Zhangjiang Description, Business Overview
4.11.3 Fudan-Zhangjiang Liposome Drug Delivery Products Offered
4.11.4 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
4.11.5 Fudan-Zhangjiang Liposome Drug Delivery Sales by Product in 2023
4.11.6 Fudan-Zhangjiang Liposome Drug Delivery Sales by Application in 2023
4.11.7 Fudan-Zhangjiang Liposome Drug Delivery Sales by Geographic Area in 2023
4.11.8 Fudan-Zhangjiang Recent Development
5 Breakdown Data by Type
5.1 Global Liposome Drug Delivery Sales by Type (2019-2030)
5.1.1 Global Liposome Drug Delivery Sales by Type (2019-2024)
5.1.2 Global Liposome Drug Delivery Sales Forecast by Type (2025-2030)
5.1.3 Global Liposome Drug Delivery Sales Market Share by Type (2019-2030)
5.2 Global Liposome Drug Delivery Revenue Forecast by Type (2019-2030)
5.2.1 Global Liposome Drug Delivery Revenue by Type (2019-2024)
5.2.2 Global Liposome Drug Delivery Revenue Forecast by Type (2025-2030)
5.2.3 Global Liposome Drug Delivery Revenue Market Share by Type (2019-2030)
5.3 Liposome Drug Delivery Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Liposome Drug Delivery Sales by Application (2019-2030)
6.1.1 Global Liposome Drug Delivery Sales by Application (2019-2024)
6.1.2 Global Liposome Drug Delivery Sales Forecast by Application (2025-2030)
6.1.3 Global Liposome Drug Delivery Sales Market Share by Application (2019-2030)
6.2 Global Liposome Drug Delivery Revenue Forecast by Application (2019-2030)
6.2.1 Global Liposome Drug Delivery Revenue by Application (2019-2024)
6.2.2 Global Liposome Drug Delivery Revenue Forecast by Application (2025-2030)
6.2.3 Global Liposome Drug Delivery Revenue Market Share by Application (2019-2030)
6.3 Liposome Drug Delivery Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Liposome Drug Delivery Market Size YoY Growth 2019-2030
7.2 North America Liposome Drug Delivery Market Facts & Figures by Country
7.2.1 North America Liposome Drug Delivery Sales by Country (2019-2030)
7.2.2 North America Liposome Drug Delivery Revenue by Country (2019-2030)
7.3 North America Liposome Drug Delivery Sales by Type (2019-2024)
7.4 North America Liposome Drug Delivery Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Liposome Drug Delivery Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Liposome Drug Delivery Market Facts & Figures by Region
8.2.1 Asia-Pacific Liposome Drug Delivery Sales by Region (2019-2030)
8.2.2 Asia-Pacific Liposome Drug Delivery Revenue by Region (2019-2030)
8.3 Asia-Pacific Liposome Drug Delivery Sales by Type (2019-2024)
8.4 Asia-Pacific Liposome Drug Delivery Sales by Application (2019-2024)
9 Europe
9.1 Europe Liposome Drug Delivery Market Size YoY Growth 2019-2030
9.2 Europe Liposome Drug Delivery Market Facts & Figures by Country
9.2.1 Europe Liposome Drug Delivery Sales by Country (2019-2030)
9.2.2 Europe Liposome Drug Delivery Revenue by Country (2019-2030)
9.3 Europe Liposome Drug Delivery Sales by Type (2019-2024)
9.4 Europe Liposome Drug Delivery Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Liposome Drug Delivery Market Size YoY Growth 2019-2030
10.2 Latin America Liposome Drug Delivery Market Facts & Figures by Country
10.2.1 Latin America Liposome Drug Delivery Sales by Country (2019-2030)
10.2.2 Latin America Liposome Drug Delivery Revenue by Country (2019-2030)
10.3 Latin America Liposome Drug Delivery Sales by Type (2019-2024)
10.4 Latin America Liposome Drug Delivery Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Liposome Drug Delivery Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Liposome Drug Delivery Market Facts & Figures by Country
11.2.1 Middle East and Africa Liposome Drug Delivery Sales by Country (2019-2030)
11.2.2 Middle East and Africa Liposome Drug Delivery Revenue by Country (2019-2030)
11.3 Middle East and Africa Liposome Drug Delivery Sales by Type (2019-2024)
11.4 Middle East and Africa Liposome Drug Delivery Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Liposome Drug Delivery Supply Chain Analysis
12.2 Liposome Drug Delivery Key Raw Materials and Upstream Suppliers
12.3 Liposome Drug Delivery Clients Analysis
12.4 Liposome Drug Delivery Sales Channel and Sales Model Analysis
12.4.1 Liposome Drug Delivery Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Liposome Drug Delivery Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Liposome Drug Delivery Distributors
13 Market Dynamics
13.1 Liposome Drug Delivery Industry Trends
13.2 Liposome Drug Delivery Market Drivers
13.3 Liposome Drug Delivery Market Challenges
13.4 Liposome Drug Delivery Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
听
听
*If Applicable.